Back
Results - Announcements
Sales rise 3.35% to Rs 161.21 crore
Lincoln Pharmaceuticals consolidated net profit declines 4.77% in the September 2024 quarter
14-Nov-2024, 01:44
Net profit of Lincoln Pharmaceuticals declined 4.77% to Rs 26.33 crore in the quarter ended September 2024 as against Rs 27.65 crore during the previous quarter ended September 2023. Sales rose 3.35% to Rs 161.21 crore in the quarter ended September 2024 as against Rs 155.99 crore during the previous quarter ended September 2023.
Net profit of Lincoln Pharmaceuticals declined 4.77% to Rs 26.33 crore in the quarter ended September 2024 as against Rs 27.65 crore during the previous quarter ended September 2023. Sales rose 3.35% to Rs 161.21 crore in the quarter ended September 2024 as against Rs 155.99 crore during the previous quarter ended September 2023.
| Particulars | Quarter Ended | ||
| Sep. 2024 | Sep. 2023 | % Var. | |
| Sales | 161.21 | 155.99 | 3 |
| OPM % | 17.60 | 19.97 | - |
| PBDT | 38.01 | 39.45 | -4 |
| PBT | 34.78 | 36.87 | -6 |
| NP | 26.33 | 27.65 | -5 |
Powered by Capital Market - Live News